New approaches to therapy for mastocytosis: A case for treatment with kit kinase inhibitors

Hematology/Oncology Clinics of North America

Volumn 14, Issue 3, 2000, Pages 689-695

  Longley, B J ^a   Ma, Yongsheng ^a   Carter, Eric ^a   McMahon, Gerald ^b  

^a Columbia University ^*  (United States)

^b SUGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL]PROPIONIC ACID; CROMOGLYCATE DISODIUM; INDOLINONE DERIVATIVE; PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE INHIBITOR; STEM CELL FACTOR; SU 4984; SU 5614; SU 6577; SU 6663; UNCLASSIFIED DRUG;

DRUG ACTIVITY; DRUG SCREENING; ENZYME INHIBITION; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; MAST CELL DEGRANULATION; MASTOCYTOSIS; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTO ONCOGENE; PUVA; REVIEW;

EID: 0033936862     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70302-6     Document Type: Article

References (22)

1. C. Buttner B.M. Henz P. Welker et al: Identification of activating c-kit mutations in adult, but not in childhood-onset indolent mastocytosis: A possible explanation for divergent clinical behavior J Invest Dermatol 111 1998 1227 1231
2. R. Devinney W.V. Gold Establishment of two dog mastocytoma cell lines in continuous culture Am J Respir Cell Biol 3 1990 413 420
3. T.B. Dunn M. Potter A transplantable mast-cell neoplasm in the mouse J Natl Cancer Inst 18 1957 587 601
4. T. Furitsu T. Tsujimura T. Tono Identification of mutations in the coding sequence of the proto-oncogene c- kit in a human mast cell leukemia cell line causing ligand-independent activation of c- kit product J Clin Invest 92 1993 1736 1744
5. S. Hirota K. Isozaki Y. Moriyama Gain-of-function mutations of c- kit in human gastrointestinal stromal tumors Science 279 1998 577 580
6. H. Kitayama Y. Kanakura T. Furitsu Constitutively activating mutations of c- kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines Blood 85 1995 790 798
7. S.C. Lazarus R. DeVinney L.J. McCabe Isolated canine mastocytoma cells: Propagation and characterization of two cell lines Am J Physiol 251 1986 935 944
8. Y. Ma B.J. Longley X. Wang Clustering of activating mutations in c- KIT's juxtamembrane coding region in canine mast cell neoplasms J Invest Dermatol 112 1999 165 170
9. B.J. Longley T.P. Duffy S. Kohn The mast cell and mast cell disease J Am Acad Dermatol 32 1995 545 561
10. B.J. Longley L. Tyrrell Lu S.-Z. Somatic c- KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis; establishment of clonality in a human mast cell neoplasm Nat Genet 12 1996 312 314
11. Longley B.J. Jr D.D. Metcalfe M. Tharp Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis Proc Natl Acad Sci U S A 96 1999 1609 1614
12. Y. Ma M.E. Cunningham X. Wang Inhibition of spontaneous receptor phosphorylation by residues in a putative α-helix in the KIT intracellular juxtamembrane region J Biol Chem 274 1999 13399 13402
13. Y. Ma B.J. Longley E. Carter Indolinone derivatives inhibit constitutively activated KIT mutants and kill neoplastic mast cells J Invest Dermatol 114 2000 392 394
14. F.H. Martin S.V. Suggs K.E. Langley Primary structure and functional expression of rat and human stem cell factor DNAs Cell 63 1990 203 211
15. M. Mohammadi G. McMahon L. Sun Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors Science 276 1997 955 960
16. H. Nagata A.S. Worobec C.K. Oh Identification of a point mutation in the catalytic domain of the protooncogene c- kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder Proc Natl Acad Sci U S A 92 1995 10560 10564
17. X. Piao R. Paulson Van Der Geer P. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1 Proc Natl Acad Sci U S A 93 1996 14665 14669
18. F. Qiu P. Ray K. Brown Primary structure of c- kit : Relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v- kit involves deletion of extracellular domain and C terminus EMBO J 7 1988 1003 1011
19. L. Sun N. Tran F. Tang Synthesis and biological evaluations of 3-substituted indolin-2-ones: A novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases J Med Chem 41 1998 2588 2603
20. T. Tsujimura T. Furitsu M. Morimoto Ligand-independent activation of c- kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation Blood 83 1994 2619 2626
21. T. Tsujimura M. Morimoto K. Hashimoto Constitutive activation of c- kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain Blood 87 1996 273 283
22. Yarden Y. Kuang W.-J. T. Yang-Feng Human proto-oncogene c- kit : A new cell surface receptor tyrosine kinase for an unidentified ligand EMBO J 6 1987 3341 3351